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Introduction {#sec1}
============

Mammalian embryonic development occurs via systematic and dynamic transitions through multiple sequential stages ([@bib43]). For the pluripotent cells of the epiblast, the transition from the pre-implantation to post-implantation embryo is the major landmark when fundamental molecular changes occur, distinguishing two distinct states of pluripotency. These states can now be captured *in vitro* as naive and primed states ([@bib24]), respectively, in both mouse ([@bib4], [@bib9], [@bib22], [@bib30], [@bib42]) and human pluripotent stem cell cultures ([@bib6], [@bib10], [@bib14], [@bib27], [@bib29], [@bib32], [@bib33], [@bib38]). While the molecular machinery has been extensively studied for human primed, mouse primed, and mouse naive pluripotency states, the regulatory pathways governing the human naive state remain to be dissected. This endeavor is crucial, because: (1) naive human embryonic stem cells (hESCs) serve as a useful *in vitro* model of early human development, which is practically and ethically challenging to study *in vivo*; (2) naive cultures are more favorable than primed cultures in certain biological aspects---for example, the latter exhibits higher heterogeneity and more variability during multi-lineage differentiation ([@bib25]); and (3) it has been put forward that certain small molecules act differently in mouse and human pluripotent states ([@bib37], [@bib39]). A major hurdle for studying the human naive state is that, unlike mouse naive and human primed states, its establishment and/or maintenance remains dependent on feeders. A defined feeder-free culture condition for the *in vitro* counterpart of human pre-implantation blastocyst will ease the mechanistic dissection of naive identity and facilitate the use of these cells in the clinic.

Consistent with different signaling requirements, naive cells are molecularly distinct from primed conventional human pluripotent cultures. They express naive-specific transcription factors such as KLF4, KLF5, DPPA3, and DPPA5, express higher levels of NANOG, display nuclear-specific localization of TFE3, and preferentially utilize the distal *POU5F1* enhancer ([@bib3], [@bib32], [@bib31]). These characteristics and their overall transcriptome closely resemble the *in vivo* intracellular matrix of human pre-implantation blastocyst ([@bib31]). Notably, the naive and primed pluripotent states are each associated with a distinct repertoire of expressed transposons, robustly reflecting profiles of their counterparts *in vivo* ([@bib11], [@bib31]). For example, primed hESCs are maintained by expression of *HERVH* driven by the *LTR7* element ([@bib19]), while naive hESCs are marked by activity of the *LTR7Y* elements ([@bib11], [@bib31]) as well as expression of *HERVK* driven by *LTR5_Hs* ([@bib13], [@bib31]). The high specificity of ERV promoters, especially throughout the course of embryonic development ([@bib11]), provides a unique approach for identification of cell states beyond existing *in vitro* models.

In this study, we took advantage of the specific activity of *LTR7Y* in naive pluripotency as a tool for establishment of feeder-free naive culture conditions. By combining a sensitive stage-specific endogenous retrovirus (ERV) reporter with a high-throughput chemical screen, we identified novel molecules that we utilized to create human feeder-independent naive embryonic (FINE) stem cells.

Results {#sec2}
=======

Small-Molecule Screen for Conditions Supporting Maintenance of the Human Naive Pluripotent State in the Absence of Feeders {#sec2.1}
--------------------------------------------------------------------------------------------------------------------------

We sought a culture condition that would enable the propagation of naive hESCs without feeders through a high-throughput small-molecule screen ([Figure 1](#fig1){ref-type="fig"}A). To visualize the naive state, we developed a zsGreen reporter cell line driven by the ERV element *LTR7Y*, whose expression has been shown to be specific to pre-implantation blastocyst stage embryos ([@bib11]). We confirmed that this reporter line is pluripotent ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1C), is karyotypically normal ([Figure S1](#mmc1){ref-type="supplementary-material"}D), fluoresces only in naive cells (3iL \[[@bib6]\]) and not in primed or differentiated cells ([Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F), and loses naive markers and zsGreen fluorescence upon transfer to feeder-free culture ([Figures S1](#mmc1){ref-type="supplementary-material"}F--S1H). To identify chemicals that can prevent collapse of naive hESCs upon feeder withdrawal, we passaged hESCs cultured in 3iL ([@bib6]) onto reduced Matrigel, and after attachment added small molecules into the medium ([Figure 1](#fig1){ref-type="fig"}A). For controls, we designated wells for hESCs treated only with DMSO vehicle, hESCs cultured in mTeSR (primed, thus showing baseline fluorescence), and primed hESCs freshly transferred to 3iL (primed → 3iL; this initial conversion exhibits an increase in signal despite the absence of feeders). We screened a total of 622 compounds targeting signaling pathways governing embryonic development, cell proliferation, and cell survival. The degree of preservation of the naive state was measured through the average *LTR7Y*-zsGreen fluorescence intensity per cell, 4 days after feeder withdrawal. The screen was performed across three concentrations for each compound and in triplicate, summing up to 5,967 data points ([Table S1](#mmc2){ref-type="supplementary-material"}).Figure 1Small-Molecule Screen for Feeder-free Maintenance of Naive hESCs(A) Schematic of high-throughput screen performed to identify compounds supporting feeder-free culture of naive hESCs. Dot plot presents mean *Z* scores for *LTR7Y-zsGreen* intensity results from the screen. The gray line indicates a cutoff of *Z* scores ≥2. Small molecules achieving this cutoff in at least two replicates were considered as hits (blue). Other samples (orange) and DMSO controls (red) did not pass this cutoff. A full list of scores is given in [Table S1](#mmc2){ref-type="supplementary-material"}.(B) Summary table with hits from the small-molecule screen. Asterisks denote compounds targeting pathways not previously demonstrated to play a role in establishment/maintenance of naive pluripotency.(C) Representative images of *LTR7Y-zsGreen* cells after treatment with small-molecule hits. Scale bars, 50 μm.(D) Fluorescence-activated cell sorting (FACS) quantification of *LTR7Y-zsGreen* signal after treatment with dasatinib, crenolanib, and AZD5438.

We first ensured the quality of the screen by certifying the absence of intra-plate layout biases ([Figure S1](#mmc1){ref-type="supplementary-material"}I), proper inter-plate alignment ([Figure S1](#mmc1){ref-type="supplementary-material"}J), and good correlation between replicates ([Figure S1](#mmc1){ref-type="supplementary-material"}K). *Z* scores were then calculated, and compounds that reproducibly scored above noise (*Z* \> 2 in at least two replicates) were regarded as hits ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}L). We also detected no significant cell number bias in hit selection ([Figure S1](#mmc1){ref-type="supplementary-material"}M). Finally, we manually excluded compounds that autofluoresced in the green channel as false positives. We observe that certain pathways are targeted by multiple compounds detected as hits ([Figure 1](#fig1){ref-type="fig"}B), including those previously implicated in naive pluripotency (e.g., GSK3, SRC, PDGFR) ([@bib29], [@bib32]). Collectively, these ascertain that we rigorously and reliably identified compounds that could retain a naive signature upon feeder withdrawal ([Figure 1](#fig1){ref-type="fig"}B). Indeed, reporter activity of hits can be validated by visual inspection ([Figure 1](#fig1){ref-type="fig"}C) as well as by flow cytometry ([Figure 1](#fig1){ref-type="fig"}D). In addition to small molecules targeting pathways implicated in naive pluripotency, our screen identified novel regulators of naive pluripotency such as the Bcr-Abl/Src inhibitors dasatinib and saracatinib, as well as the cyclin-dependent kinase inhibitor AZD5438, which warrant further investigation.

Development of a Stable Feeder-free Human Naive Pluripotent Culture Condition {#sec2.2}
-----------------------------------------------------------------------------

The screen provided us a list of hits that can potentially substitute for fibroblast feeders in culturing naive hESCs. To identify which of the hits might be useful for long-term culture, we first tested the effect of short-term supplementation of individual hits on naive pluripotency marker expression upon feeder withdrawal from published naive culture protocols. In 3iL ([@bib6]), only AZD5438 (CDK1/2/9 inhibitor) consistently attenuated downregulation of naive pluripotency markers including *LTR7Y* ([Figure 2](#fig2){ref-type="fig"}A), while in 4iLA ([@bib32]), only dasatinib (Bcr-Abl/Src kinase inhibitor) had the same effect ([Figure 2](#fig2){ref-type="fig"}B).Figure 2Optimization and Establishment of FINE Culture Conditions(A and B) Gene expression analysis for naive markers in (A) 3iL cultured cells and (B) 4iLA cultured cells supplemented with small molecules. Mean ± SD of three independent experiments. RNA was collected after 6 days (3iL) or 12 days (4iLA) in culture without feeders. AZD, AZD5438; CHIR, CHIR-99021; Dasa, dasatinib; Sara, saracatinib; Creno, crenolanib.(C) Relative survival of hESC culture under 4iLA supplemented with different chemical combination conditions (C1--C21) over nine passages without feeders. 4iLA was included as control. When cells appear highly differentiated morphologically or when very few cells remain after passaging, the condition is dropped off; only cells cultured in C18--C21 4iLA medium supplemented with AZD5438 and dasatinib (in green) remain after nine passages. Detailed conditions are provided in [Table S2](#mmc1){ref-type="supplementary-material"}.(D) Heatmap presenting gene expression of naive pluripotency-associated markers in cells at passage 4 during adaptation to naive feeder-free conditions (C1--C21). Mean of two biological replicates is shown. Euclidean distance from 4iLA^+^ feeder across all the genes tested was calculated for each condition and represented as the bar chart.(E) Schematic showing the process of adapting primed hESCs into FINE.(F) Gene expression in hESCs throughout the course of adaptation from mTeSR1 to FINE up to passage 5. Mean ± SD of two independent experiments.

We next sought to find a condition that enables stable naive culture by adapting feeder-free primed hESCs onto media supplemented by one or more of the hits at various concentrations ([Figure 2](#fig2){ref-type="fig"}C and [Table S2](#mmc1){ref-type="supplementary-material"}). We tested more combinations including AZD5438 and dasatinib because of their favorable effects on short-term feeder withdrawal ([Figures 2](#fig2){ref-type="fig"}A and 2B). From this point onward, we solely utilized 4iLA ([@bib32]) as our basal medium, since it is the transgene-free culture condition shown to resemble the *in vivo* epiblast most closely at the time of the experiment ([@bib23]). At passage 4, we collected RNA from all conditions and quantified transcripts of genes associated with naive pluripotency ([Figure 2](#fig2){ref-type="fig"}D), and found that condition 19 had the closest profile to 4iLA hESCs on feeder as measured by Euclidean distance. Despite retained expression of many naive pluripotency genes, culture in 4iLA without any feeders or supplementary molecules had very few cells surviving at passage 5. Upon culturing for eight passages, only conditions with both dasatinib and AZD5438 are still actively proliferating ([Figure 2](#fig2){ref-type="fig"}C). Since condition 19 exhibits the best survival profile while maintaining naive gene expression signature, we decided to focus on the long-term propagation of cells in this medium. Further optimization showed that WH-4-023, an Src kinase inhibitor originally present in 4iLA feeder-dependent culture ([@bib32]), is dispensable for both adaptation and maintenance of feeder-free naive cells ([Figure S2](#mmc1){ref-type="supplementary-material"}A), likely due to the presence of another Src inhibitor, dasatinib ([@bib1]), in condition 19. Thus, we excluded it from the final formulation and called this "feeder-independent naive ESCs" or FINE.

Our optimized protocol for adaptation in FINE culture conditions involves an initial conversion step from mTeSR1 medium on Matrigel to FINE under normoxia (P0), plus an additional five passages (P1--P5) under hypoxia on a reduced growth factor Matrigel substrate ([Figure 2](#fig2){ref-type="fig"}E). During this course, human pluripotency markers such as *POU5F1* and *PRDM14* are transiently downregulated, but return to normal levels by P5 ([Figure 2](#fig2){ref-type="fig"}F). Two trends of naive-specific marker upregulation can be observed ([Figure 2](#fig2){ref-type="fig"}F): those which are upregulated as soon as P0 and gradually increase across passages (such as *KLF4* and *DPPA3*), and those which are not upregulated until P3 onward (such as *NANOG* and *KLF17*). Primed-specific markers are generally downregulated early on at P0--P1 ([Figure 2](#fig2){ref-type="fig"}F). Taken together, adaptation in FINE does not require feeders at any step of the process, and the naive pluripotent signature is established and stabilized by P5.

FINE Cells Exhibit Hallmarks of Naive Pluripotent Cells {#sec2.3}
-------------------------------------------------------

Throughout propagation (P5 onward), FINE cells maintain the compact morphology characteristics of naive cells ([Figure 3](#fig3){ref-type="fig"}A). After sustained culture (\>8 passages), we assessed the expression pattern of FINE compared with 4iLA on feeders and observed comparable expression levels of blastocyst markers on both transcript and protein levels ([Figures 3](#fig3){ref-type="fig"}B, 3C, and [S2](#mmc1){ref-type="supplementary-material"}A), and comparable or lower expression of lineage markers ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Nuclear localization of naive-specific transcription factors KLF4, KLF17, and TFE3 is also observed in FINE, as in 4iLA on feeders ([Figures 3](#fig3){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}A). Note that while some of these naive transcription factors exhibit heterogeneous expression, the same is observed for 4iLA on feeders ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Nevertheless, naive cells express naive surface markers homogeneously ([Figure 3](#fig3){ref-type="fig"}D), suggesting that all cells in culture are of naive pluripotent identity, but transcription factor levels fluctuate as observed in non-ground-state naive ESCs in mouse ([@bib5], [@bib15], [@bib26], [@bib34], [@bib36]). Importantly, expression of stage-specific ERVs *LTR7Y* and *HERVH* in FINE mimics that of 4iLA on feeders ([Figure 3](#fig3){ref-type="fig"}E), and functional pluripotency is preserved as demonstrated by teratoma formation ([Figure S2](#mmc1){ref-type="supplementary-material"}D). FINE conditions induce naivety similarly across multiple human pluripotent cell lines ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C), confirming the robustness of this culture system. To assess self-renewal capability, we quantified the cell number of FINE cells across passages and observed ∼4-fold propagation every 4 days ([Figure 3](#fig3){ref-type="fig"}F), consistent with positive staining for proliferation marker Ki67 ([Figure S2](#mmc1){ref-type="supplementary-material"}E). This doubling rate (∼60 h) is comparable with that of 4iLA^+^ feeder (60--96 h), but is slower than primed cells in mTeSR1 (∼22 h) ([Figure S2](#mmc1){ref-type="supplementary-material"}F). X chromosome status through *in situ* hybridization of the *HUWE1* locus ([@bib28]) indicates XaXa for both FINE and 4iLA^+^ feeder, while primed cells exhibit XaXi ([Figures 3](#fig3){ref-type="fig"}G and [S2](#mmc1){ref-type="supplementary-material"}G). Transcripts indicative of X chromosome activation are similarly upregulated by approximately 2-fold or more in 4iLA^+^ feeder and FINE versus primed cells ([Figure S2](#mmc1){ref-type="supplementary-material"}H), consistent with the switch from monoallelic to biallelic expression in XaXa cells ([@bib18]). We also observe that FINE cells exhibit lower levels of H3K9 trimethylation compared with primed mTeSR1 culture, typical of the higher proportion of euchromatin in ground-state naive pluripotent cells ([@bib35]) ([Figure 3](#fig3){ref-type="fig"}H). Taken together, these results indicate that FINE is a bona fide human naive pluripotent culture system independent of feeder support.Figure 3FINE Cells Display Hallmarks of Naive Pluripotency(A) Bright-field images of hESCs cultured in 4iLA (with and without feeders) and FINE at passage 8. Scale bars, 50 μm.(B) Expression of blastocyst-associated transcripts in hESCs cultured under mTeSR1, 4iLA^+^ feeder, and FINE conditions. Mean ± SD of three independent experiments.(C) Immunofluorescence staining of pluripotency and blastocyst-associated proteins in hESCs under mTeSR1 and FINE conditions. Scale bars, 50 μm.(D) FACS quantification of hESCs expressing naive surface markers under mTeSR1, 4iLA^+^ feeder, and FINE conditions.(E) qPCR analysis of *LTR7Y* and *HERVH* transcripts in hESCs cultured under mTeSR1, 4iLA^+^ feeder, and FINE conditions. Mean ± SD of three independent experiments.(F) Measurement of cell numbers cultured in FINE conditions at day 0 (D0) and 4 days post seeding (D4). Mean ± SD of three independent experiments.(G) Representative RNA fluorescence *in situ* hybridization (FISH) images detecting *HUWE1* (subject of X chromosome inactivation) and *XACT* control (escaping X chromosome inactivation) in mTeSR1, 4iLA^+^ feeder, and FINE cells. Scale bars, 10 μm.(H) Immunofluorescence staining of H3K9me3 in hESCs under mTeSR1 and FINE conditions (left). Scale bars, 50 μm. Intensity of H3K9me3 was quantified through a line (red) randomly drawn across images (right).

FINE Cells Are Dependent on Both Dasatinib and AZD5438 {#sec2.4}
------------------------------------------------------

Our data showed that both AZD5438 and dasatinib are crucial for the establishment of FINE cells. Therefore, we wanted to test whether both are also important for the maintenance of naivety in FINE. Withdrawal of either or both AZD5438 and dasatinib caused dispersal of the compact morphology typical of naive cultures, indicating exit from naive pluripotency ([Figure 4](#fig4){ref-type="fig"}A). This is corroborated by the reduction in nuclear staining of naive-specific transcription factors ([Figures 4](#fig4){ref-type="fig"}A and 4B) as well as the downregulation of pluripotency and naive transcripts ([Figure 4](#fig4){ref-type="fig"}C). Dasatinib withdrawal had a more pronounced effect in loss of naivety than AZD5438 withdrawal but, more importantly, markers were lost most significantly upon withdrawal of both compounds. These results indicate that these two compounds act on distinct pathways in parallel to maintain the naive pluripotent state in the absence of feeders, and supplementation of either compound alone is insufficient to sustain long-term naivety.Figure 4FINE Cells Are Dependent on Both Dasatinib and AZD5438(A) Bright-field and immunofluorescence staining of KLF4, TFE3, and KLF17 in FINE culture after withdrawal of AZD, dasatinib (Dasa), or both for three passages. Scale bars, 50 μm.(B) Quantification of fraction of nuclei positive for naive-associated transcription factors in hESCs cultured in FINE after withdrawal of AZD, Dasa, or both for three passages. Mean ± SD of three independent experiments.(C) Expression of blastocyst-associated transcripts in hESCs cultured in FINE after withdrawal of AZD, Dasa, or both for two passages. Mean ± SD of three independent qPCR experiments.(D and E) Expression of blastocyst-associated transcripts in hESCs cultured in FINE after (D) replacement of Dasa with other Src and Bcr-Abl inhibitors or (E) replacement of AZD with dinaciclib (DINA) (in H9 line) for two passages. IMA, imatinib; NILO, nilotinib. Mean ± SD of three independent qPCR experiments.

Dasatinib is a kinase inhibitor with a broad range of targets including Bcr-Abl, Src family kinases, and multiple receptor and non-receptor tyrosine kinase families ([@bib17]). We know that dasatinib affects Src, as its addition allowed removal of WH-4-023 from the FINE formulation ([Figures 3](#fig3){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}A); however, replacement of dasatinib with other Src inhibitors such as WH-4-023 and SRCi, as well as other Bcr-Abl inhibitors such as nilotinib and imatinib ([Figure 4](#fig4){ref-type="fig"}D), failed to sustain feeder-free naive hESCs. Similarly, replacement of AZD5438 with another multi-cyclin-dependent kinase inhibitor, dinaciclib (which also inhibits CDK1/2/9, but also CDK5) did not sustain FINE cells ([Figure 4](#fig4){ref-type="fig"}E). These results establish the essential role of these two compounds in sustaining feeder-free naive culture and imply that these compounds might have other unknown targets that confer such effects.

Analysis of the Global Transcriptome of FINE Cells {#sec2.5}
--------------------------------------------------

To confirm the efficacy of FINE in converting hESCs to a feeder-free naive state, we performed RNA-sequencing (RNA-seq) analysis on hESCs cultured in mTeSR1 (primed), 4iLA with feeders, and FINE. Principal component analysis and correlation confirms that FINE very closely resembles naive cells on feeders ([Figures 5](#fig5){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}A). Analysis of the top 1,000 differentially expressed genes show six major clusters, with the two biggest clusters comprising genes specifically expressed in either primed (mTeSR1) or naive (4iLA^+^ feeder, FINE) states including well-known markers such as *DNMT3L*, *DPPA5*, *KLF4*, and *TFCP2L1* ([@bib6], [@bib29], [@bib32]) ([Figure 5](#fig5){ref-type="fig"}B). In fact, differential gene expression analysis between FINE and 4iLA^+^ feeder only generates 440 genes ([Figure 5](#fig5){ref-type="fig"}C), most of which are involved in cell adhesion, cell-cell junctions, and extracellular matrix interactions ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C), reflective of the replacement of feeders with reduced Matrigel. Most of the FINE-enriched genes are also upregulated in feeder-free primed mTeSR1 culture ([Figure S4](#mmc1){ref-type="supplementary-material"}C), suggesting that these genes play a role in adaptation to feeder-independent *in vitro* culture. Allocation of differentially expressed genes between FINE and mTeSR1 onto published stage-specific genes of the human developing embryo ([@bib40], [@bib41]) assigns FINE closest to the late blastocyst stage *in vivo* and far from primed pluripotent cultures ([Figures 5](#fig5){ref-type="fig"}D \[left\] and [S4](#mmc1){ref-type="supplementary-material"}D).Figure 5Transcriptomic Profile of FINE Resembles the *In Vivo* Pre-implantation Blastocyst(A) Principal component (PC) analysis based on top 1,000 differentially expressed genes between mTeSR1, 4iLA^+^ feeder, and FINE cultured cells.(B) Heatmap of top 1,000 differentially expressed genes between mTeSR1, 4iLA^+^ feeder, and FINE cultured cells. Six main clusters were defined by dendrogram (left). Representative genes from two main clusters (naive-specific genes, primed-specific genes) are presented in smaller heatmaps (right).(C) Scatterplots showing significantly upregulated (in red) and downregulated (in blue) genes between: mTeSR versus 4iLA^+^ feeder, mTeSR1 versus FINE, and 4iLA^+^ feeder versus FINE conditions. Genes not differentially expressed are presented in black.(D) Correspondence between gene expression (left) or transposable element (TE) expression (right) between our naive/primed ESCs and single-cell human embryonic stages from [@bib41]. For each embryonic stage, the percentage of genes/TEs with expression upregulated in FINE (green), upregulated in mTeSR1 (dark gray) or unchanged between FINE and mTESR1 (light gray) is shown.(E) PC analysis plot based on the top 2,540 repeat elements differentially expressed across conditions. Single-cell *in vivo* embryonic data ([@bib41]) are represented as squares, while FINE, 4iLA^+^ feeder, and mTeSR1 from our bulk RNA-seq data are drawn as circles.(F) Box plots representing mean normalized expression of different TEs in mTeSR1, 4iLA^+^ feeder, and FINE cultured cells.(G) Percentage of members in each TE family with expression upregulated in FINE (green), upregulated in mTeSR1 (dark gray), or unchanged between FINE and mTESR1 (light gray). TE families were ranked as specific to FINE conditions on the left and specific to mTeSR1 conditions on the right.

Expression profiles of repetitive and transposable elements have been demonstrated to be highly stage specific ([@bib11]), and can be used as a sensitive barometer for matching pluripotent cultures with stages of *in vivo* early human development ([@bib31]). Analysis of this "transposcriptome" matched FINE cells with the 8-cell-to-blastocyst stages of the human embryo ([Figures 5](#fig5){ref-type="fig"}D \[right\] and 5E), with FINE cells very closely resembling hESCs cultured in 4iLA^+^ feeder ([Figures 5](#fig5){ref-type="fig"}E, 5F, and [S4](#mmc1){ref-type="supplementary-material"}E). Transposable elements upregulated in FINE versus primed cells include known naive-specific families such as *LTR5-Hs*, *LTR7Y*, and *HERVK* ([@bib11], [@bib13], [@bib31]) ([Figures 5](#fig5){ref-type="fig"}F and 5G). Overall, FINE cells are transcriptionally equivalent to naive pluripotent culture with feeders, and closely resemble the *in vivo* pre-implantation blastocyst.

Analysis of Global DNA Methylation in FINE Cells {#sec2.6}
------------------------------------------------

To examine the chromatin status of FINE cells, we profiled global DNA methylation status in FINE cells compared with mTeSR1 and 4iLA^+^ feeder cells. Across all chromosomes, the percentage of methylated CG sites is equivalently lower in cells cultured in both naive conditions compared with primed hESCs ([Figures 6](#fig6){ref-type="fig"}A and 6B), consistent with previous reports of global DNA hypomethylation in the naive pluripotent state ([@bib29], [@bib31]). In fact, the methylated regions for FINE and 4iLA^+^ feeder are very highly correlated ([Figures 6](#fig6){ref-type="fig"}B and 6C), corroborating that these naive pluripotent states are equivalent. Consistent with transcript expression patterns, DNA at naive marker loci, as well as at 8C and morula-associated gene loci, are less methylated in FINE and 4iLA^+^ feeders, while differentiation genes display higher DNA methylation ([Figure 6](#fig6){ref-type="fig"}D). All in all, global DNA methylation profiling supports that FINE represents a feeder-free equivalent of 4iLA-cultured naive hESCs.Figure 6Global DNA Methylation Profile of FINE Confirms Equivalence to Feeder-Dependent Naive Pluripotent hESCs(A) Per-chromosome comparison of CG methylation fraction between mTeSR1, 4iLA^+^ feeder, and FINE conditions.(B) Relative methylation tracks of chromosome 4 under mTeSR1, 4iLA^+^ feeder, and FINE conditions.(C) Correlation plot of methylated sites in FINE versus either mTeSR1 or 4iLA^+^ feeder. Red line represents fit based on linear regression modeling (off-center best fit indicates lower correlation); blue line is based on LOESS weighted regression modeling (curved best-fit line indicates non-linear correlation).(D) Box plots (top) for CG methylation fraction at select loci representing naive-, differentiation-, 8C-, and morula-associated genes, as well as relative methylation tracks of one representative gene per group (bottom). Differential peaks are highlighted in yellow for *ZSCAN4* and *DNAJC15*.

Advantages and Applications of FINE Cells {#sec2.7}
-----------------------------------------

To test the utility of FINE cells for applications such as genetic targeting, we compared the amenability of naive cells to DNA delivery via transfection. Using an mCherry-expressing plasmid to report transfection efficiency and by co-staining with CD75 to exclude feeders from quantification, we observed more than 5-fold double-positive cells in FINE than in 4iLA^+^ feeder cells ([Figures 7](#fig7){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}A). Moreover, we tested the ease of genome editing under FINE using the CRISPR/Cas9 system. Using guide RNAs targeting human-specific sequences, we observed that hESCs had no significant difference in terms of gene-editing efficiency between FINE and 4iLA^+^ feeder conditions (independent of transfection efficiency, as only positively transfected cells were utilized) ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Thus, combined with the general simplicity of handling associated with the absence of feeders, these results indicate that FINE culture allows for easier genetic targeting of naive hESCs.Figure 7FINE Cells Offer Advantages over Other Naive Culture Conditions(A) Representative images (left) and FACS quantification (right) of cells in FINE and 4iLA^+^ feeder culture conditions after transfection with mCherry-containing plasmids gRNA 1 (targeting *EGFR*) and gRNA 2 (targeting *STAG2*). Quantification was performed after staining with an anti-CD75 antibody to account for feeders; mean ± SD of two independent experiments. Scale bar, 400 μm.(B) Summary of cytogenetic analysis of H9 cells (top) under various naive culture conditions (rows) and passage numbers (columns). Representative karyotypes at various passage numbers in FINE (bottom).(C) qPCR analysis of naive-associated transcripts in H1 hESCs cultured under mTeSR1, RSeT, and FINE conditions. Mean ± SD of three independent experiments.(D) Heatmap showing rlog values for expression of 8-cell- and morula-stage-associated genes in mTeSR1, 4iL^+^ feeder, and FINE cultures based on RNA-seq.

One of the main disadvantages of current human naive culture conditions is its inherent genomic instability ([@bib32]). FINE cells are karyotypically normal up to passage 12, indicating that FINE cells are not an artifact of spontaneous genetic abnormalities ([Figure 7](#fig7){ref-type="fig"}B). Importantly, comparative cytogenetic analysis across various passage numbers indicate that FINE cells acquire chromosomal abnormalities at a slower rate than 4iLA^+^ feeder cells ([Figure 7](#fig7){ref-type="fig"}B), albeit having similar proliferation kinetics ([Figure S2](#mmc1){ref-type="supplementary-material"}F). To further improve this, we tried lowering the concentration of PD0325901 in FINE, following a recent study that demonstrated enhanced genetic stability upon lower dosage of MEK inhibition ([@bib7]). While this further delayed the acquisition of chromosomal abnormalities ([Figure 7](#fig7){ref-type="fig"}B), it had a slight adverse effect on naive pluripotent marker expression ([Figure S5](#mmc1){ref-type="supplementary-material"}C). Conversely, extended culture in FINE (P24) does not repress (but actually even slightly increases) naive marker expression, despite chromosomal defects ([Figure S5](#mmc1){ref-type="supplementary-material"}D).

We also compared how FINE fares against RSeT, a commercially available feeder-free medium for naive hESCs, based on [@bib10]. We find that upregulation of naive markers is greater and more consistent in FINE ([Figure 7](#fig7){ref-type="fig"}C), including markers that have been reported to be upregulated by RSeT culture. Finally, we also observe that markers associated with earlier stages of development (such as the 8-cell stage) are slightly enhanced in FINE compared with 4iLA on feeder ([Figures 7](#fig7){ref-type="fig"}D and [S5](#mmc1){ref-type="supplementary-material"}E). Taken together, FINE improves on existing naive culture conditions by offering robust naive marker expression, including 8-cell stage-specific transcripts, under feeder-free conditions, while improving genomic stability and amenability to gene-editing techniques.

Discussion {#sec3}
==========

ERVs as Molecular Landmarks for Cellular States {#sec3.1}
-----------------------------------------------

Here, we exploited the stage-specific transcription of ERVs during embryogenesis to generate an ERV-based *LTR7Y* fluorescent reporter, and demonstrated its utility in an unbiased chemical screen that led us to establishment of a feeder-free naive medium composition. Our results and research in mouse ESCs ([@bib20]) indicate that with the help of accurate and sensitive reporters such as ERVs, it is possible to isolate a cell state beyond existing *in vitro* models. Application of a similar strategy can be used for generation of cellular models that correspond to cells from stages of development other than the blastocyst, and enable further understanding of the requirements for establishment of cellular potency and initiation of cell-fate decisions, which is still largely inaccessible to research.

Applications of Feeder-free Naive hESCs {#sec3.2}
---------------------------------------

Until now a number of protocols using various cocktails of molecules has been reported to induce naive states mimicking *in vitro* human pre-implantation epiblast ([@bib6], [@bib10], [@bib29], [@bib32], [@bib38]). In these studies, establishment of human naive medium composition was guided by previous knowledge obtained from the mouse. However, species-specific differences exist between mouse and human pluripotency. For example, GSK3 inhibitor is commonly used in naive cocktails, and acts in mouse ESCs by elevating levels of Esrrb ([@bib21]). In contrast, ESRRB is not expressed in human pluripotent states ([@bib39]) either *in vivo* (blastocyst\'s inner cell mass) or *in vitro* (primed and naive hESCs), suggesting that GSK3 inhibition might act via a different mechanism in human naive pluripotent culture. In addition, naive hESCs hitherto have been dependent on feeders, a fact that introduces a non-defined component and hampers both their acceptance in clinical use and the application of certain technical approaches for dissection of mechanisms behind the state. So far, there are only two feeder-free alternatives for naive culture of hESCs: the first is RSeT medium (based on [@bib10]), which we and others have shown to have divergent transcriptional and epigenetic profiles from best-in-class naive culture systems ([@bib2], [@bib23]) ([Figure 7](#fig7){ref-type="fig"}C); the second is the protocol from Smith and colleagues ([@bib14]), whose caveats include the requirement for HDAC inhibitors, which are known to increase susceptibility to genomic instability ([@bib8]), and the multi-step derivation process that still undergoes temporary culture on feeders for stabilization. Here, we developed a simple feeder-independent system called FINE that can be used for both the establishment and sustenance of the human naive state. Conversion to naive cells in FINE is a one-step process that does not require the use of non-defined components. Therefore, FINE provides a purely chemically defined xeno-free platform for further dissection of the mechanisms controlling human early development. This is especially useful in dissecting the role of the various small molecules that define human naive pluripotent culture. Absence of feeders also allows for unbiased high-throughput screens for identification of novel contributors to the naive state without the complication of secondary phenotypes from extraneous supporting cells not normally found in embryonic development *in vivo*. FINE also enables easy genetic targeting of naive hESCs, not only through the ease of handling due to its feeder-free nature (e.g., removing the requirement for antibiotic-resistant feeders for selection), but also because of its inherent amenability to such techniques ([Figures 7](#fig7){ref-type="fig"}A, [S5](#mmc1){ref-type="supplementary-material"}A, and S5B). We also observe that FINE cells acquire chromosomal abnormalities slower ([Figure 7](#fig7){ref-type="fig"}B), suggesting that our system also improves genetic stability compared with its feeder-dependent counterparts. Thus, FINE culture has the potential to be the go-to system for establishment, propagation, and examination of human naive pluripotent cells.

Mechanism of Action of Effective Compounds in FINE {#sec3.3}
--------------------------------------------------

The unique ability of FINE to support naive hESCs in the absence of feeders is endowed by the synergistic action of two compounds, AZD5438 and dasatinib. Dasatinib is a broad kinase inhibitor affecting multiple receptor and non-receptor tyrosine kinase families ([@bib17]). One of its known targets that play a role in naive pluripotency is Src, but it must target other additional pathways because other Src inhibitors are unable to sustain feeder-free naive hESCs ([Figure 4](#fig4){ref-type="fig"}D). On the other hand, AZD5438 inhibits cyclin-dependent kinases 1 and 2, which largely act in checkpoints of the S and G~2~ phases of the cell cycle. We have demonstrated before that prolonging these phases of the cell cycle restricts exit from pluripotency in primed hESCs ([@bib12]), and AZD5438 might act in this manner to maintain pluripotency in the absence of feeders. Yet, like dasatinib, replacement of AZD5438 with another CDK1/2/9 inhibitor was not sufficient to sustain FINE cells. Thus, while beyond the scope of this paper, it is tempting to speculate that these compounds, together or alone, affect unprecedented pathways to induce and maintain feeder-free naivety. Furthermore, several of these compounds\' known target pathways have not been studied in the context of naive pluripotency, and, as such, dissecting the mechanisms of these compounds will be an exciting avenue to pursue in the future. Finally, given that these compounds were discovered in an unbiased screen, it is possible that the combination of AZD5438 and dasatinib, and perhaps other hits from our screen, may be applicable to endow feeder independence in other culture systems beyond naive hESCs.

In conclusion, we first identified novel molecules that facilitate feeder independence of naive hESC culture, which could be useful to guide studies in understanding how fibroblast feeders provide an artificial niche for stem cell culture *in vitro*. Second and more importantly, through rigorous optimization, we developed a simple chemically defined xeno-free method of establishing and maintaining naive hESCs called FINE. This platform offers technical advantages for the mechanistic dissection of naive identity and will serve as a useful foundation for translational applications of naive pluripotent stem cells.

Experimental Procedures {#sec4}
=======================

All animal experiments were approved by the A^∗^STAR Institutional Animal Care and Use Committee (IACUC) following the National Advisory Committee for Laboratory Animal Research (NACLAR) Guidelines. All animals were kept in pathogen-free conditions in the AAALAC-accredited A^∗^STAR animal facility.

Human Primed and Naive Cell Cultures {#sec4.1}
------------------------------------

H1 (WA-01) line was used for all experiments unless specified otherwise. Other lines used are HES3 (ES-03), H9 (WA-09), and induced pluripotent stem (GM23338) cells. Primed hESCs were propagated in mTeSR1 (STEMCELL Technologies). Cells were cultured on 30× diluted Matrigel matrix-coated (Corning) dishes under normoxia (37°C, 21% O~2~, 5% CO~2~). Culture medium was refreshed daily. Cells were subcultured using 1 mg/mL dispase in DMEM/F12 (STEMCELL) every 3--6 days according to manufacturer\'s protocol. 3iL cultured cells were propagated as previously described ([@bib6]). 4iLA^+^ feeder cells were cultured as previously described ([@bib32]). Cells were cultured in hypoxic conditions (5% O~2~, 5% CO~2~). Medium was refreshed daily. Cells were subcultured using TrypLE (Life Technologies) every 4--7 days. H1 mTeSR cells were adapted to RSeT feeder-free culture conditions following the manufacturer\'s protocol (STEMCELL). Cells were cultured in hypoxic conditions (5% O~2~, 5% CO~2~).

Conversion of Primed hESCs to Naive hESCs with FINE Culture {#sec4.2}
-----------------------------------------------------------

Primed cells were seeded on 30× diluted Matrigel at a passage ratio of 1:6. Cells were seeded in clumps and kept in mTeSR1 culture for 48 h. For conversion to naive cell state, we removed mTeSR1 medium and added FINE culture medium, which consists of a basal medium (1:1 ratio of F12 DMEM and Neurobasal \[Gibco\] medium, 1× N2 supplement \[Gibco\], 1× B2 supplement \[Gibco\], 1× L-glutamine (Gibco), 1× non-essential amino acids \[Gibco\], 0.1 mM β-mercaptoethanol \[Sigma\], and 62.5 ng/mL BSA \[Sigma\]) supplemented with 0.1 μM dasatinib (Selleckchem), 0.1 μM AZD5438 (Tocris), 0.1 μM SB590885 (Sigma), 1 μM PD0325901 (Sigma), 10 μM Y-27632 (STEMCELL), 20 ng/mL human recombinant leukemia inhibitory factor (Peprotech), 20 ng/mL activin A (STEMCELL), and 8 ng/mL basic fibroblast growth factor (Gibco). Cells were incubated under normoxic conditions (21% O~2~, 5% CO~2~) for 4--5 days. FINE culture medium was replenished daily. At the end of conversion, cells were passaged as single cells using TrypLE (Gibco) solution on Reduce Growth Factor Matrigel-coated (Corning) plates (dishes were coated for at least 1 h before use). In brief, cells were washed with 1× PBS, and 500 μL of TrypLE was added to each 3.5-cm well (6-well plate, Falcon) of hESCs. Cells were incubated at 37°C for 1--2 min. When cells started to detach from each other and remained adherent to the plate, TrypLE was aspirated thoroughly and washed with 1× PBS. After adding 1 mL of FINE medium, cells were gently detached using a cell scraper and clumps dissociated to single cells with a 1-mL pipette. Cells were seeded at a high ratio of 1:2 in coated plates and transferred to a hypoxia (5% O~2~, 5% CO~2~) incubator for subsequent culture. Medium was refreshed daily. FINE culture cells were subsequently passaged at ratios of 1:2 to 1:4. For most cell lines, differentiated cells were observed in the first 2--3 passages and gradually decreased over subsequent passages. For the experiments described, FINE cells were cultured in medium for at least five passages before use, unless otherwise described.

FINE low PD03 cells were adapted from FINE conditions at passage 12. PD0325901 (Sigma) concentration was reduced from 1 μM to 0.3 μM.

Reporter Line Generation {#sec4.3}
------------------------

LTR7Y element (chr17:32,515,593-32,516,013, hg19) was cloned into modified pLVTH-zsGreen plasmid (Addgene \#12262). LTR7Y element was inserted between the PacI and SalI cloning sites. H1 hESCs were seeded at clonal density and transduced with lentivirus in the presence of 4 μg/mL Polybrene (Sigma). Cells were reseeded as single cells for generation of clonal lines for further study.

High-Throughput Small-Molecule Screen {#sec4.4}
-------------------------------------

Three thousand cells cultured in 3iL were seeded per well into 384-well plates (Greiner) coated with 30× growth factor reduced Matrigel (Corning) in 45 μL of medium. Four hours after seeding, cells were treated with anti-cancer and anti-kinase libraries (Selleckchem; kinase inhibitor screening library: customized collection of 273 kinase inhibitors; anti-cancer compound library: customized collection of 349 bioactive compounds). Small molecules were used at three different concentrations: 100 nM, 1 μM, and 10 μM. Forty-eight hours after the treatment, culture medium was renewed concomitant with a second round of treatment. Forty-eight hours after the second round of treatment, cells were fixed with 4% formaldehyde (Sigma) and stained with Hoechst 33342 dye (1:4,000, Invitrogen). Images were taken using an Opera Phenix High-Content Screening System (PerkinElmer) at 20× magnification. Images were processed and fluorescence signal was quantified using a Columbus Image Data Storage and Analysis System (PerkinElmer). Screen analyses were carried out using Screensifter software ([@bib16]). *Z* score for zsGreen fluorescence was calculated using formula *z* = (*X* − *μ*)/s.d., where *μ* is the mean, s.d. the standard deviation of the whole population, and *X* the integrated intensity of zsGreen divided by total number of cells.

850K DNA Methylation Profiling {#sec4.5}
------------------------------

Genomic DNA was isolated by a DNeasy Blood & Tissue Kit (Qiagen) and processed using a Zymo EZ DNA Methylation kit (Zymo Research, CA, USA) following the manufacturer\'s recommendations for bisulfide conversion. An Infinium MethylationEPIC BeadChip (Illumina) was used to interrogate the genome-wide methylation profile following the Infinium HD methylation assay protocol.
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